BSF Enterprise
BSFA · Main Market · Health Care · mcap £2.4m · 1.1p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 23 Sep 26 | Key US patent for ETSYL Technology
BSF Enterprise Plc (LSE: BSFA), (OTCQB: BSFAF), the biotechnology company focused on developing tissue engineering, lab-grown materials, and bioactive solutions, is pleased to announce that the United States Patent and T |
+18.4% | |
| 08 Sep 26 | Routine | Publication of a Prospectus | |
| 25 Aug 26 | Conversion of Convertible Loan Notes
BSF Enterprise Plc (LSE: BSFA), (OTCQB: BSFAF), the biotechnology company focused on tissue engineering, lab-grown materials and bioactive solutions, announces that it has received a notice from Indigo Capital Investment |
−8.0% | |
| 17 Aug 26 | LGL Ultra-Lux Automotive & Advanced Robotics Skin
Lab-Grown Leather for Ultra-Luxury Automotive & Advanced Robotics Skin |
+8.7% | |
| 11 Aug 26 | Worldwide Commercialisation of ETSYL
Worldwide Exclusive Commercialisation of ETSYL® in Luxury Cosmetics & Skincare |
+13.9% | |
| 03 Aug 26 | Heads of Terms - US Joint Venture
Heads of Terms Executed for US Joint Venture |
+41.2% | |
| 24 Jul 26 | Routine | Updated TR-1 | |
| 24 Jul 26 | Routine | TR-1 from Alvar | |
| 30 Jun 26 | Results | Interim 2026 Results
BSF (LSE: BSFA), (OTCQB: BSFAF), a leading innovator in tissue-engineered materials is pleased to announce its unaudited interim results for the six months ending 31 March 2026. |
+0.0% |
| 26 Jun 26 | BSF Wins Cannes 2026 Awards for T-Rex Leather
BSF Subsidiary Wins Major Accolades at Cannes Lions 2026 for T-Rex Leather™ |
+0.0% | |
| 16 Jun 26 | Auction Operational Update & Strategic Progress
Paris Auction Operational Update & Platform Strategic Progress |
+2.3% | |
| 12 Jun 26 | Paris Auction Result
BSF Enterprise Plc ("BSF" or the "Company"), an investor in next-generation bio-sustainable technologies , provides an update following the Tentation°4 sale managed by Giquello SAS at the Hôtel Drouot auction house in Pa |
−43.8% | |
| 11 Jun 26 | £1 Million Convertible Loan Note
BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has entered into an interest-free Convertible Loan Note Instrument (the "CLN") w |
−15.8% | |
| 08 Jun 26 | Results | Shareholder meeting results
BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that at the Company's General Meeting held earlier today, all resolutions proposed were |
−10.0% |
| 03 Jun 26 | Conditional Further Investment
BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has conditionally placed 25,000,000 new ordinary shares in the Company ("Placing |
−20.0% | |
| 02 Jun 26 | Technical White Paper on T-Rex Leather™
Publication of Technical White Paper on T-Rex Leather™ |
+38.9% | |
| 28 May 26 | Auction Update - May 2026
BSF Enterprise PLC ("BSF" or the "Company"), a biotech platform company driving a bio-sustainable future, announces updates to the planned auction of Lab-Grown Leather Ltd (BSF's wholly owned subsidiary) unique T-rex lea |
+0.0% | |
| 26 May 26 | Strategic Update May 2026
BSF Enterprise PLC ("BSF" or the "Company"), a biotech platform company driving a bio-sustainable future through its three high-growth subsidiaries, announces updates to its strategic operations for 1/2-year 2026. |
+10.3% | |
| 22 May 26 | Routine | Posting of Circular and Notice of General Meeting | |
| 05 May 26 | T-Rex Leather™ handbag to be auctioned
A Historic Milestone in Luxury and Biotechnology - |
+14.3% | |
| 17 Apr 26 | Admission of Shares
Further to the announcement published on 02 April 2026, BSF Enterprise PLC ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, announces that 38,500,000 ordinary shares of £0.01 each in the issu |
+0.0% | |
| 13 Apr 26 | Strategic Shareholding Update
BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce, further to the Company's announcement of 2 April 2026 regarding the placing of new ordi |
+23.1% | |
| 07 Apr 26 | World’s First T-Rex Leather Handbag Unveiled
BSF Enterprise PLC (LSE: BSFA; OTCQB: BSFAF), a leader in the field of tissue engineering and sustainable biotechnology, is pleased to announce the successful unveiling of the world's first handbag made from cultivated T |
+5.9% | |
| 02 Apr 26 | Further Investment and Appointment of Adviser
BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has placed 38,500,000 new ordinary shares in the Company ("Placing Shares") rais |
+130.5% | |
| 02 Apr 26 | World First T-Rex Leather™ Product
BSF Enterprise PLC (LSE: BSFA; OTCQB: BSFAF), a leader in the field of lab-grown tissues and sustainable biotechnology, is pleased to announce the unveiling of the world's first product made from lab-grown T-Rex Leather™ |
+130.5% | |
| 19 Mar 26 | Supply Agreement with SeaWith
BSF Enterprise PLC (LSE: BSFA) (the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that its subsidiary, 3D Bio-Tissues Limited ("3DBT"), has entered into a five-year commercial Sup |
+0.0% | |
| 17 Mar 26 | LGL Tanning Milestones
BSF Enterprise PLC (LSE: BSFA), the tissue-engineering innovator, is pleased to report a major technical and commercial milestone for its wholly-owned subsidiary, Lab-Grown Leather Ltd ("LGL"). |
+24.6% | |
| 13 Mar 26 | Fundraise | Further Update on Fundraise & Reorganisation
Further Update on Proposed £15m Equity Fundraise and Capital Reorganisation |
−50.0% |
| 10 Mar 26 | First Tannable A4-Sized Skin Achieved
Scalable Process Unlocked for Elemental™; T-Rex Leather™ Showcase Confirmed for 2 April 2026 |
+38.9% | |
| 03 Mar 26 | Routine | Result of AGM | |
| 27 Feb 26 | Fundraise | Update on Proposed Equity Fundraise
Update on Proposed Equity Fundraise and Capital Reorganisation |
−23.9% |
| 09 Feb 26 | Notice of AGM
BSF Enterprise PLC (LSE:BSFA) (the "Company") a leading innovator in tissue engineered materials, is pleased to announce The Notice of the Annual General Meeting (to be held at 10a.m. |
+0.0% | |
| 03 Feb 26 | Annual Financial Report - Correction
BSF Enterprise PLC (LSE: BSFA), a leading innovator in tissue-engineered materials, advises in relation to its Annual Report and Consolidated Financial Statements for the year ended 30 September 2025 released yesterday, |
+0.0% | |
| 02 Feb 26 | Results | Annual Report
BSF Enterprise PLC (LSE: BSFA), a leading innovator in tissue-engineered materials, is pleased to announce that its Annual Report and Consolidated Financial Statements for the year ended 30 September 2025 have been publi |
+0.0% |
| 19 Jan 26 | Kerato Limited Signs With Quebec Pso Grant
KERATO LIMITED SIGNS WITH QUEBEC PSO GRANT TO SUPPORT VETERINARY TRIALS AND ACCELERATE NORTH AMERICAN MARKET ENTRY |
+1.8% | |
| 17 Dec 25 | Routine | Result of General Meeting | |
| 16 Dec 25 | 3D Bio-Tissues Signs Supply Agreement with SeaWith
3D Bio-Tissues Limited Signs Commercial Supply Agreement with SeaWith |
+2.4% | |
| 15 Dec 25 | Fundraise | Changes to timetable for proposed Equity Fundraise
Changes to timetable for proposed Equity Fundraise and Capital Reorganisation |
−10.6% |
| 05 Dec 25 | BSF Enterprise launches new Investor website
BSF Enterprise PLC (LSE:BSFA) (the "Company") a leading innovator in tissue engineered materials, is pleased to announce the launch of our interactive investor website. |
+21.4% | |
| 01 Dec 25 | Fundraise | Proposed Equity Fundraise - Strategic Direction
BSF Enterprise PLC (LSE: BSFA), a leading innovator in tissue-engineered materials ("BSF" or the "Company"), is pleased to provide further information on the expected strategic direction from the proceeds of its proposed |
−50.5% |
| 01 Dec 25 | Fundraise | Equity Fundraise & Notice of General Meeting
Convertible Loan, Proposed Equity Fundraise and Capital Reorganisation |
−50.5% |
Company filings. Not investment advice.